Federal contract award
HQ014714C0001
MRBM TARGETS
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | MISSILE DEFENSE AGENCY (MDA) |
| NAICS | 336414 — Guided Missile and Space Vehicle Manufacturing |
| PSC | 1337 — Guided Missile and Space Vehicle Explosive Propulsion Units, Solid Fuel; and components |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIXED PRICE INCENTIVE |
| Obligations | $1.2B |
| Current contract value | $1.3B |
| Potential contract value / ceiling | $1.4B |
| Start date | Oct 31, 2013 |
| Current end date | Dec 31, 2029 |
| Potential end date | Dec 31, 2029 |
| Latest award activity | Jun 4, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 200 of 268 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 10, 2026 | ARZ991 | $0 | NOVATION ON AEROJET. NAME CHANGE, ADDRESS CHANGE, DCMA LOCATION CHANGE, PAY OFFICE CHANGE |
| Jun 4, 2026 | P00265 | $0 | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Apr 30, 2026 | P00264 | $0 | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Apr 21, 2026 | P00263 | $37.7M | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Mar 16, 2026 | P00262 | $-4.4M | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Mar 5, 2026 | P00261 | $0 | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Jan 20, 2026 | P00260 | $0 | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Dec 22, 2025 | P00259 | $39.4M | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Dec 19, 2025 | P00258 | $2.3M | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Dec 16, 2025 | P00257 | $0 | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Dec 11, 2025 | P00256 | $10.0M | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Nov 6, 2025 | P00255 | $0 | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Oct 23, 2025 | P00254 | $0 | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Oct 6, 2025 | P00253 | $0 | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Sep 25, 2025 | P00252 | $244.4K | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Sep 12, 2025 | P00251 | $0 | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Sep 5, 2025 | P00250 | $650.0K | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Aug 1, 2025 | P00247 | $0 | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Aug 1, 2025 | P00248 | $33.9M | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Aug 1, 2025 | P00249 | $2.4M | 1) EXERCISE ONE (1) OPTION QUANTITY FROM CLIN 0900 AIR LAUNCH TARGET PREPARATION (BASELINE MISSION): A) REMOVE CEILING VALUE FROM CLIN 0900 AT THE FY 25 RATE FOR A TOTAL PRICE OF $3,412,805 ($3,068,848 COST + $343,957 PROFIT) AND B.) INCREASE CLIN 0057 CEILING VALUE FOR FTM 43. |
| Jul 11, 2025 | P00246 | $0 | SUPPORT MEDIUM RANGE BALLISTIC MISSILE T1/T2 TARGETS |
| Jun 6, 2025 | P00245 | $400.0K | CLIN NARRATIVE UPDATE, TIS, IF |
| May 28, 2025 | P00244 | $13.8M | IF |
| May 13, 2025 | P00243 | $2.0M | 100 TO59 OP EX, TOI, POP EXT, CLIN CLEANUP |
| May 6, 2025 | P00242 | $437.0K | OPTION EXERCISE (CLIN 0700 'PRE-MISSION ANALYSIS & KIT G OPTION FOR FTT-26 (TAIL 8)" TO CLIN 0058) IF |
| Apr 3, 2025 | P00241 | $14.0M | IF FUNDING ONLY - VARIOUS CLINS |
| Apr 2, 2025 | P00240 | $0 | CLAUSE UPDATE CLIN 0039 NO COST POP EXT INCORPORATE PIFAL |
| Mar 31, 2025 | P00239 | $-0 | DODAAC UPDATE, GFP ATTACHMENT UPDATE, DEOB CLIN 0227, INCORPORATION OF TI-063 REV-3 |
| Mar 26, 2025 | P00238 | $0 | TI, CLAUSE UPDATE, CLIN 0216 CEILING OVERRUN CORRECTION |
| Mar 14, 2025 | P00237 | $-40.8K | TIS, POP EXT, OPEX CORRECTION, DE-OB |
| Feb 14, 2025 | P00236 | $6.5M | ESR-19 DEVELOPMENT PDR TO CDR |
| Feb 12, 2025 | P00235 | $399.0K | CLIN 0216 OVERRUN, ATT 16 UPDATE, IF, TI, ESM, POP EXTENSION |
| Feb 3, 2025 | P00234 | $25.7M | IF, DE-OB CLIN 0018, ESM, TIS, POP EXTENSIONS, PIFAL LETTER |
| Jan 17, 2025 | P00233 | $114.6K | CLIN 0313 DPLH, POP EXT, TIS |
| Dec 19, 2024 | P00232 | $3.0M | CLIN 0084 CY25 PMO SUPPORT OPTION EXERCISE |
| Dec 6, 2024 | P00231 | $2.0M | POP EXTENSIONS, IF, TIS |
| Dec 4, 2024 | P00230 | $2.0M | CLIN 0024 OVERRUN, TIS, CDRL UPDATE |
| Nov 22, 2024 | P00229 | $15.5M | INCREMENTAL FUNDING |
| Nov 19, 2024 | P00228 | $0 | TIS, POP EXTENSIONS, ADMIN ACTIONS |
| Nov 13, 2024 | P00227 | $5.0M | ESR-19 DEVELOPMENT PDR TO CDR |
| Nov 4, 2024 | P00226 | $7.2M | INCREMENTAL FUNDING FOR CLINS 0051, 0059, & 0213 |
| Oct 9, 2024 | P00225 | $0 | TI 037 FINAL, TI 041 FINAL, TI 044 FINAL, TI 046 REV 9, TI 049 FINAL, TI 051 REV 4 |
| Sep 30, 2024 | P00224 | $1.3M | CLIN 0091 & IF |
| Sep 25, 2024 | P00223 | $-1 | DE-OB , TIS, PGI UPDATE |
| Sep 9, 2024 | P00222 | $0 | PWS REV 38, DATED 26 AUGUST 2024,TI-040 REV 4, OBSOLESCENCE MITIGATION, TI-046 REV 8, BDDC BRACKET,TI-057 REV 4, SN0005 STATIC FIRE TEST, TI-066 REV 1, CAMDEN AR QSMA ASSESSMENT, ATTACHMENT 40 QSMA MATRIX |
| Aug 16, 2024 | P00221 | $382.6K | OPTION EXERCISE CLIN 0008 TO CLIN 0039 (FTX-40) |
| Aug 12, 2024 | P00220 | $0 | INCORPORATE TI-051 REV 3, UPDATE ATT 12 OPTION EXERCISE TABLES REV 2 DATED 08 AUG 2024 |
| Jul 30, 2024 | P00219 | $1.5M | TI 064 REV 1, ESM POP EXTENSIONS, CLIN 0016 PR, UPDATE SECTION B CLIN NARRATIVE |
| Jul 25, 2024 | P00218 | $231.0K | CLIN 0092 OVERRUN, CORRECTIVE ACTION: OPT. EX. CLIN 0700/0900 TO CLIN 0059 KIT C (SUB-OPTION), TI UPDATE |
| Jul 16, 2024 | P00217 | $8.9M | ATTACHMENT 17 UPDATE, TI, IF, CLIN 0227 OVERRUN |
| Jun 28, 2024 | P00216 | $2.6M | CLIN 0011 TO CLIN 0039 (FTX-40), CLIN 0007 INCREMENTAL FUNDING, TI, PGI CLAUSE UPDATE |
| Jun 17, 2024 | P00215 | $14.2M | ESR-19 DEVELOPMENT PDR TO CDR |
| Jun 11, 2024 | P00214 | $30.0M | IF FUNDING |
| May 10, 2024 | P00213 | $33.4M | ESR-19 DEVELOPMENT PDR TO CDR |
| May 8, 2024 | P00212 | $0 | INCORPORATE TI-062 REV 1, CLIN 0201 POP EXTENSION, UPDATE ATT 30 PMO SUPPORT POP |
| Apr 22, 2024 | P00211 | $0 | ESR-19 DEVELOPMENT PDR TO CDR |
| Apr 16, 2024 | P00210 | $12.8M | ESR-19 DEVELOPMENT PDR TO CDR |
| Apr 15, 2024 | P00209 | $2.5M | ESR-19 DEVELOPMENT PDR TO CDR |
| Mar 26, 2024 | P00208 | $0 | ESR-19 DEVELOPMENT PDR TO CDR |
| Mar 13, 2024 | P00207 | $1.9M | ESR-19 DEVELOPMENT PDR TO CDR |
| Mar 11, 2024 | P00206 | $0 | ESR-19 DEVELOPMENT PDR TO CDR |
| Mar 1, 2024 | P00205 | $-943.6K | ESR-19 DEVELOPMENT PDR TO CDR |
| Feb 27, 2024 | P00204 | $7.3M | IF CLINS 0016, 0083, 0538, 0536, 0518, 0509, AND 0515 |
| Feb 26, 2024 | P00203 | $6.7M | OPTION EXERCISE & IF |
| Feb 21, 2024 | P00202 | $0 | CLIN 0001 NO COST POP EXT, CLIN 0213 HOURS AND RATE CORRECTION, TARGET 3 PIFAL, TI-46 REV 5 NO COST POP EXT, MULTIPLE CLINS FUNDING. |
| Feb 9, 2024 | P00200 | $0 | UPDATE NO COST POP EXTENSIONS, PGI ACRN DATA |
| Jan 24, 2024 | P00199 | $-150.8K | CLIN 0018 CPFF DEOBL |
| Jan 11, 2024 | P00198 | $281.0K | CLIN 0001 OVERRUN PROPOSAL, 46113-23-3098 AND FUNDING |
| Dec 21, 2023 | P00197 | $14.6M | EXERCISE OPTION FTX 43, CLIN 0037 AND FUNDING |
| Dec 4, 2023 | P00196 | $5.2M | EXERCISE CLIN 0083, PMO FY 2024 AND OVERRUNS PROPOSALS (CLIN 0227, 46113-23-3034 & CLIN 0024, 46113-23-3069) |
| Nov 29, 2023 | P00195 | $1.8M | INCREMENTAL FUNDING (UNILATERAL) |
| Nov 17, 2023 | P00194 | $-7.0M | DEOBL CLIN 0065 & CLIN 0213, TI 064 AND ESM 013 REV 8 |
| Nov 3, 2023 | P00193 | $0 | CLIN 0020 POP EXT AND INCORPORATE 2 ESM AND 2 TI'S TO CONTRACT |
| Oct 19, 2023 | P00192 | $0 | ADMINISTRATIVE MOD FOR SECTION J CHANGES |
| Sep 26, 2023 | P00191 | $0 | POP EXT FOR CLINS 0014, 0016, 0227, 0502, 0503, 0504, 0510, 0511, 0517, 0518 PGI CLAUSE 204-7108(D)(12) ACRN ORDER UPDATE DFARS CLAUSE 252.232-7006 DODAAC UPDATE PIFAL FOR TARGET 2 UPDATE TI 046 REV 3 TO POP EXT CLIN 0213 |
| Sep 15, 2023 | P00190 | $0 | CLIN 0003 POP EXTENSION. WAWF CLAUSE 252.232-7007 UPDATE FOR PAYMENT INSTRUCTIONS. |
| Sep 8, 2023 | P00189 | $0 | WAWF CLAUSE 252.232-7007 UPDATE FOR PAYMENT INSTRUCTIONS. |
| Aug 31, 2023 | P00188 | $0 | CEILING INCREASE CLIN 0213 AND TRANSFER CEILING CLIN 0007 |
| Aug 17, 2023 | P00187 | $1.3M | IF CLIN 0513 |
| Aug 11, 2023 | P00186 | $4.1M | IF, DE-OB, UPDATE ATTACHMENTS |
| Jul 11, 2023 | P00185 | $0 | TRANSFER CEILING VALUE FROM CLINS 0038 TO 0007 AND CLINS 0018 TO CLINS 0213 |
| Jun 22, 2023 | P00184 | $-966.0K | OBLIGATIONS AND DEOBLIGATION |
| Jun 15, 2023 | P00183 | $3.2M | EXERCISE OPTION FTX 023 AND FUNDING |
| May 25, 2023 | P00182 | $3.4M | CLIN 0227 OVERRUN 46113-23-2909 AND FUNDING |
| May 16, 2023 | P00181 | $12.0M | INCREMENTAL FUNDS |
| May 10, 2023 | P00180 | $0 | CLIN 0213 CEILING INCREASE |
| Apr 20, 2023 | P00179 | $8.1M | INCREMENTAL FUNDING CLINS 0513, 0514, 0529 AND 0536 |
| Apr 18, 2023 | P00178 | $10.7M | OPTION EXERCISE AND FUNDING CLIN 0058 |
| Apr 11, 2023 | P00177 | $7.0M | FUNIDNG |
| Apr 7, 2023 | P00176 | $0 | RE-NEGOTIATED KIT G MISSION PLANNING OPTIONS |
| Mar 29, 2023 | P00175 | $10.0M | ADMIN, INCREMENTAL FUNDING AND INCORPORATE TI |
| Mar 21, 2023 | P00174 | $0 | ESR-19 DEVELOPMENT PDR TO CDR |
| Mar 13, 2023 | P00173 | $18.5M | ESR-19 DEVELOPMENT PDR TO CDR |
| Mar 9, 2023 | P00172 | $8.1M | ESR-19 DEVELOPMENT PDR TO CDR - CLIN 0024 OVERRRUN |
| Mar 3, 2023 | P00171 | $23.3M | MRBM LAUNCH VEHICLE (NON-RECURRING) OPTION EX |
| Feb 9, 2023 | P00170 | $0 | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Jan 17, 2023 | P00169 | $0 | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Dec 15, 2022 | P00168 | $3.5M | ADMINISTRATIVE ACTION AND FUNDING |
| Nov 30, 2022 | P00167 | $11.5M | CHANGE ORDER LOT 3, ENHANCED ATTITUDE CONTROL SYSTEM AND SYSTEM VERIFICATION TEST |
| Oct 28, 2022 | P00166 | $1 | POP EXTENSIONS AND TASK INSTRUCTIONS |
| Sep 28, 2022 | P00165 | $3.0M | MRBM LAUNCH VEHICLE (NON-RECURRING)FUNDING, INCORPORATE TI & ESM & OVERRUN |
| Sep 15, 2022 | P00164 | $7.6M | FUNDING AND ADMINISTRATIVE |
| Aug 22, 2022 | P00163 | $2.6M | MRBM LAUNCH VEHICLE (NON-RECURRING) OPTION CLIN 0009 EXERCISE |
| Aug 10, 2022 | P00162 | $11.5M | EXERCISE OPTIONS FOR FTM 37, FTX 40 AND FTM 43 |
| Jul 14, 2022 | P00161 | $6.0M | FUNDING AND ADMIN ACIONS |
| Jun 27, 2022 | P00160 | $2.9M | MRBM LAUNCH VEHICLE (NON-RECURRING)MP FOR TAILS 7-12 & CLIN 0227 OVERRUN |
| Jun 7, 2022 | P00159 | $12.9M | CLIN 0024 OVERRUN |
| May 26, 2022 | P00158 | $8.5M | MRBM LAUNCH VEHICLE (NON-RECURRING)INCREMENTAL FUNDING |
| May 13, 2022 | P00157 | $7.1M | MRBM LAUNCH VEHICLE (NON-RECURRING)- IF |
| May 11, 2022 | P00156 | $2.9M | MRBM LAUNCH VEHICLE (NON-RECURRING)EXERCISE OPTION CLIN 0009 QTY 2 |
| Apr 21, 2022 | P00155 | $0 | ADMIN CORRECTION TO P00149 & P00151 INACCURACIES |
| Apr 12, 2022 | P00154 | $2.2M | VARIOUS POP EXTENSIONS AND FUNDING |
| Mar 22, 2022 | P00153 | $0 | POP EXTENSIONS FOR CLIN(S) 0020, 0038, 0053 AND 0215. |
| Mar 21, 2022 | P00152 | $300.0K | INCORPORATE NEGOTIATION SETTLEMENT OF INTEGRATED LOGISTICAL SUPPORT, CLIN 0005 |
| Mar 8, 2022 | P00151 | $3.0M | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Feb 18, 2022 | P00150 | $9.1M | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Feb 11, 2022 | P00149 | $19.1M | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Dec 8, 2021 | P00148 | $5.0M | OPTION EXERCISE OF CLIN 0081 |
| Dec 2, 2021 | P00147 | $2.5M | INCREMENTAL FUNDING $2.5M |
| Nov 9, 2021 | P00146 | $0 | VARIOUS ADMINISTRATION ACTIONS |
| Sep 15, 2021 | P00145 | $428.5K | INCREMENTAL FUNDING CLINS 0047 & 0049 |
| Aug 30, 2021 | P00144 | $16.7M | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Aug 19, 2021 | P00143 | $500.0K | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Aug 3, 2021 | P00142 | $200.0K | EXERCISE AN OPTION: MISSION CLIN 0037 |
| Jul 2, 2021 | P00141 | $15.0M | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Jun 8, 2021 | P00140 | $325.0K | REALLOCATE $400,000 CEILING VALUE FROM CLIN 0013 TO 0014 AND INCREMENTAL FUNDS CLIN 0021 ($0.79) AND CLIN 0045 ($325,000) |
| Apr 30, 2021 | P00139 | $8.5M | EXERCISE OPTION CLIN (0038) FTX 45 |
| Apr 1, 2021 | P00138 | $14.6M | CLIN(S) 0217 & 0227 OVERRUNS, OPTION EXERCISE, INCREMENTAL FUNDING |
| Mar 8, 2021 | P00137 | $19.1M | EXERCISE OF OPTION CLIN 0039 PRE-MISSION ANALYSIS |
| Feb 19, 2021 | P00136 | $15.6M | PRE MISSION ANALYSIS, CLIN 0007 AWARD AND INCREMENTAL FUNDING CLINS 0016 & 0024 |
| Jan 12, 2021 | P00135 | $3.6M | THE PURPOSE OF THIS MODIFICATION IS TO: 1. INCREMENTALLY FUND CLIN 0024 IN THE AMOUNT OF $3,591,229.00 |
| Dec 2, 2020 | P00134 | $1.1M | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Nov 17, 2020 | P00133 | $9.9M | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Nov 3, 2020 | P00132 | $-4.7M | PROGRAM MANAGEMENT OFFICE SUPPORT EXTENSION AND INCREMENTAL FUNDING. |
| Sep 2, 2020 | P00131 | $965.8K | PROGRAM MANAGEMENT OFFICE SUPPORT EXTENSION AND INCREMENTAL FUNDING. |
| Aug 20, 2020 | P00130 | $856.3K | INCREMENTAL FUNDING |
| Aug 4, 2020 | P00129 | $-2.6M | KIT GENERATION 2 AIRBORNE LAUNCH EQUIPMENT (ALE) FOR TARGET OBJECT (TO)-ALE |
| Jun 24, 2020 | P00128 | $11.2M | ESR-19 CONFIGURATION CHANGE&INCREMENTAL FUNDING |
| Jun 1, 2020 | P00127 | $337.7K | THIS MODIFICATION IS FOR THE INCORPORATION OF CLIN 0090 FOR PRFAB. |
| Mar 27, 2020 | ARZ997 | $0 | COVID-19 DIB. MRBM TARGETS |
| Mar 16, 2020 | P00126 | $38.9M | THIS MODIFICATION IS FOR THE INCORPORATION OF CLIN 0215 FOR KIT C2 AO INTEGRATION. |
| Feb 26, 2020 | P00125 | $41.2M | INCREMENTAL FUNDING |
| Feb 19, 2020 | P00124 | $5.7M | THIS MODIFICATION IS FOR THE INCORPORATION OF CLIN 0217 FOR ROLL CONTROL SUPPORT EQUIPMENT AND TO ADD INCREMENTAL FUNDING. |
| Dec 20, 2019 | P00122 | $0 | THIS MODIFICATION IS FOR THE DEFINITIZATION OF UNPRICED CHANGE ORDER (UCO) ON CLIN 0227 FOR CONTINUED PERFORMANCE OF THE ROLL CONTROL OBSOLESCENCE EFFORT. |
| Dec 20, 2019 | P00123 | $4.1M | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Nov 21, 2019 | P00121 | $5.4M | MRBM LAUNCH VEHICLE (NON-RECURRING)- FUNDING FOR ROLL CONTROL SYSTEM. |
| Nov 18, 2019 | P00120 | $21.2M | MRBM LAUNCH VEHICLE (NON-RECURRING)FUNDING AND ADMIN MODIFICATION |
| Sep 11, 2019 | P00119 | $0 | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Aug 28, 2019 | P00118 | $4.8M | MRBM LAUNCH VEHICLE (NON-RECURRING) CLIN 0024 ESR19 DEVELOPMENT PDR TO CDR |
| Aug 12, 2019 | P00117 | $0 | MRBM LAUNCH VEHICLE RECURRING PRODUCTION; TAILS 2-6 |
| Jul 30, 2019 | P00116 | $669.7K | CLIN 0227 ROLL CONTROL SYSTEM UCO |
| Jul 2, 2019 | P00115 | $0 | SETTLE REAS AND ADMINISTRATIVE ACTIONS. |
| Jun 20, 2019 | P00114 | $22.5M | MRBM LAUNCH VEHICLE, ADDITIONAL TARGETS REQUIREMENT. |
| May 29, 2019 | P00113 | $0 | ADMINISTRATIVE ACTION ON CLIN 0028, 0013, AND 0018. |
| Apr 15, 2019 | P00112 | $928.6K | FUNDING FOR CLIN 0002 AND CLIN 0004 |
| Mar 27, 2019 | P00111 | $1.8M | ADMINISTRATIVE CONTRACT CORRECTIONS TO CLIN 0001, CLIN 0011 AND CLIN 0032, AND INCORPORATING TI, ESM, INCENTIVE PLAN TO SECTION J |
| Mar 1, 2019 | P00110 | $-573.7K | EXERCISE AN OPTION QUANTITY FROM CLIN 0008 EXERCISE AN OPTION QUANTITY FROM CLIN 0011 OVERRUN CLIN 0001 REALIGNMENT OF FUNDS |
| Feb 11, 2019 | P00109 | $0 | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Jan 14, 2019 | P00108 | $21.3M | INCREASING THE CEILING VALUE ON CLINS 0002 AND 0004 TO MAXIMUM CEILING VALUE, AND EXERCISING AN OPTION ON CLIN 0031. |
| Dec 16, 2018 | P00107 | $41.9M | ESR-19 UCO DEFINITIZATION |
| Dec 4, 2018 | P00106 | $5.5M | INCREMENTAL FUNDING FOR CLIN 0019 AND 0027 |
| Nov 14, 2018 | P00105 | $0 | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Oct 4, 2018 | P00104 | $0 | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Oct 3, 2018 | P00103 | $0 | CLIN 11 RE PRICING AND ESM |
| Sep 21, 2018 | P00101 | $-6.7M | INCREMENTAL FUNDING DEOBLIGATION ONLY. |
| Sep 21, 2018 | P00102 | $6.7M | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Sep 19, 2018 | P00100 | $84.6K | INCREMENTALLY FUND CLIN 32 IN THE AMOUNT OF $84,622.00 |
| Sep 14, 2018 | P00099 | $42.8K | INCREMENTAL FUNDING FOR CLIN 0032 |
| Sep 13, 2018 | P00097 | $-1.0M | DEOBLIGATE FUNDING FROM CLIN 0027 FOR THE PURPOSE OF REALIGNMENT |
| Sep 13, 2018 | P00098 | $1.0M | REALIGNMENT OF FUNDS. |
| Sep 12, 2018 | P00096 | $1.1M | CLIN 0009 RE-PRICE EFFORT AND INCREMENTAL FUNDING FOR CLIN 0023 AND 0032. |
| Sep 11, 2018 | P00095 | $-2.9M | INCREMENTAL FUNDING FOR CLIN 0021 |
| Aug 29, 2018 | P00094 | $1.8M | INCREMENTAL FUNDING FOR CLINS 0021 AND 0032. |
| Aug 22, 2018 | P00093 | $0 | THE PURPOSE OF THIS MODIFICATION IS TO UPDATE SECTION J, ENGINEERING SERVICE MEMORANDUM (ESM), TO INCORPORATE ESM 001 REV 1, 003 REV 1 , 005 REV 1, 007 REV 1, 011 REV 1, 016 REV 1 AND 020 REV 1 IN TO THE CONTRACT AND TO INCORPORATE ESR-19 IP ASSERTIONS INTO SECTION J. |
| Aug 9, 2018 | P00092 | $1.1M | INCREMENTAL FUNDING MODIFICATION |
| Jul 29, 2018 | P00091 | $9.2M | CLIN 0028 UCO |
| Jul 24, 2018 | P00090 | $0 | CORRECTIONS TO DFAS INVOICING |
| Jul 20, 2018 | P00089 | $1.7M | INCREMENTAL FUNDING FOR CLIN 0020 |
| Jul 6, 2018 | P00088 | $50.0K | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| May 31, 2018 | P00087 | $0 | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| May 30, 2018 | P00086 | $2.3M | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| May 15, 2018 | P00085 | $12.8M | MOD P00085 AWARDS CLINS 0019 AND 0027, INCORPORATES ESMS, AND OBLIGATES INCREMENTAL FUNDING. |
| May 2, 2018 | P00084 | $24.9M | INCREMENTALLY FUND CLIN'S 0001, 0007, 0020, AND 0021. |
| Apr 19, 2018 | P00083 | $2.0M | MOD P00083 ADMINISTRATIVE ACTION TO CORRECT CLIN 0018 DESCRIPTION |
| Apr 10, 2018 | P00082 | $0 | ADMINISTRATIVE MODIFICATION TO NOVATE THE CONTRACT |
| Mar 23, 2018 | P00081 | $57.7K | CLIN 0008 POST MISSION ANALYSIS FOR MISSIONS 1-6 RE-PRICE EFFORT. |
| Mar 15, 2018 | P00080 | $8.1M | INCREMENTAL FUNDING FOR CLIN'S 0001, 0007, AND 0020. |
| Mar 13, 2018 | ARZ998 | $0 | MRBM TARGETS |
| Mar 13, 2018 | P00079 | $542.8K | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Feb 15, 2018 | P00078 | $0 | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Jan 25, 2018 | P00077 | $0 | MOD P00077 ADMINISTRATIVE CHANGE |
| Jan 12, 2018 | P00076 | $6.6M | MRBM LAUNCH VEHICLE (NON-RECURRING) JEON ACCELERATION |
| Dec 15, 2017 | P00075 | $0 | INCORPORATE ETHERNET FLIGHT PROOF TESTING INTO KIT C CLIN 0003 ON MOD P00075 |
| Nov 16, 2017 | P00074 | $4.3M | INCREMENTAL FUNDING, CDRL REVISION, DELIVERY SCHEDULE REVISION |
| Oct 30, 2017 | P00073 | $3.5M | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Sep 29, 2017 | P00072 | $3.0M | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Sep 19, 2017 | P00070 | $0 | MRBM LAUNCH VEHICLE (NON-RECURRING) |
| Sep 19, 2017 | P00071 | $186.3K | MODIFICATION P00071 TO EXTEND THE PERIOD OF PERFORMANCE ON TI-023 REV 5 TO 30 SEP 17. |
| Jul 27, 2017 | P00069 | $15.0M | INCREMENTALLY FUND CLINS 0002, 0003, AND 0018 |
| Jul 24, 2017 | P00068 | $9.4M | EXERCISE OPTION KITS F AND G. FUND ESMS 002, 004, 005, AND 006 CLIN 0018. |
Estimated positioning window
Dec 31, 2028 – Jun 30, 2029
Modeled likelihood: 45%. These are AcornBids estimates, not confirmed solicitation dates.
{
"psc": "1337",
"naics": "336414",
"agency": "Department of Defense",
"office": "MISSILE DEFENSE AGENCY (MDA)",
"incumbent": "AEROJET ROCKETDYNE COLEMAN AEROSPACE INC",
"known_forecast": false,
"option_end_date": "2029-12-31",
"contract_end_date": "2029-12-31",
"latest_action_date": "2026-06-04",
"modification_count": 268,
"previous_solicitation": "HQ014712R0005",
"historical_award_count": 2,
"historical_cadence_days": 39
}Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.